Heparin, the life saving blood thinner used in major surgeries and treatment of heart diseases, is a complicated drug but a research team from the University of British Columbia has set out to make its use a lot safer by developing a universal antidote.
Heparin's blood thinning action often requires an antidote to reverse its effect before serious bleeding issues arise especially in the case of major surgical procedures.